NEW YORK (AP) — Stocks are falling as a $41 billion deal between drugmakers Merck and Schering-Plough does little to jolt investors out of their pessimistic mood.
chicagotribune.com -, Chicago Tribune
Mon, 03/09/2009 - 6:44am
NEW YORK (AP) — Stocks are falling as a $41 billion deal between drugmakers Merck and Schering-Plough does little to jolt investors out of their pessimistic mood.